CDC-Authored Genomics and Precision Health Publications Database

---

Last data update: Mar 21, 2025. (Total: 6600 publications)

All Cancer Diabetes Economic Equity Environmental FHH HLBS ID Implementation ND PGx PI Rare RCH dataset

Filtered By: Select to fine-tune your search Year Journal

Records 1-13 (of 13 Records)

Query Trace: Konopka-Anstadt JL[original query]
Genetic stabilization of attenuated oral vaccines against poliovirus types 1 and 3 Yeh MT , Smith M , Carlyle S , Konopka-Anstadt JL , Burns CC , Konz J , Andino R , Macadam A . Nature 2023 619 (7968) 135-142
Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial Wilkinson AL , Zaman K , Hoque M , Estivariz CF , Burns CC , Konopka-Anstadt JL , Mainou BA , Kovacs SD , An Q , Lickness JS , Yunus M , Snider CJ , Zhang Y , Coffee E , Abid T , Wassilak SGF , Pallansch MA , Oberste MS , Vertefeuille JF , Anand A . Lancet Infect Dis 2023 23 (9) 1062-1071
Evaluation of the safety, immunogenicity, and faecal shedding of novel oral polio vaccine type 2 in healthy newborn infants in Bangladesh: a randomised, controlled, phase 2 clinical trial. Zaman K , Bandyopadhyay AS , Hoque M , Gast C , Yunus M , Jamil KM , Mainou BA , Konopka-Anstadt JL , Hendley WS , Vincent A , Clemens R , Clemens SAC , Ross AG , Clemens JD , Tritama E . Lancet 2022 401 (10371) 131-139
Genetic and phenotypic stability of poliovirus shed from infants who received novel type 2 or Sabin type 2 oral poliovirus vaccines in Panama: an analysis of two clinical trials. Wahid R , Mercer LD , De Leon T , DeAntonio R , Sáez-Llorens X , Macadam A , Chumakov K , Strating J , Koel B , Konopka-Anstadt JL , Oberste MS , Burns CC , Andino R , Tritama E , Bandyopadhyay AS , Aguirre G , Rüttimann R , Gast C , Konz JO . Lancet Microbe 2022 3 (12) e912-e921
Fecal shedding of two novel live attenuated oral poliovirus type 2 vaccines candidates by healthy bOPV/IPV-vaccinated infants: two randomized clinical trials. Gast C , Bandyopadhyay AS , Sáez-Llorens X , De Leon T , DeAntonio R , Jimeno J , Aguirre G , McDuffie LM , Coffee E , Mathis DL , Oberste MS , Weldon WC , Konopka-Anstadt JL , Modlin J , Bachtiar NS , Fix A , Konz J , Clemens R , Costa Clemens SA , Rüttimann R . J Infect Dis 2022 226 (5) 852-861
Evaluating stability of attenuated Sabin and two novel type 2 oral poliovirus vaccines in children. Wahid R , Mercer L , Gast C , De Leon T , Sáez-Llorens X , Fix A , Macadam A , Stephens L , Chumakov K , Smits SL , Murreddu M , Konopka-Anstadt JL , Steven Oberste M , Burns CC , Andino R , Bachtiar NS , Tritama E , Bandyopadhyay AS , Aguirre G , Rüttimann R , Konz JO . NPJ Vaccines 2022 7 (1) 19
Assessment of genetic changes and neurovirulence of shed Sabin and novel type 2 oral polio vaccine viruses. Wahid R , Mercer L , Macadam A , Carlyle S , Stephens L , Martin J , Chumakov K , Laassri M , Petrovskaya S , Smits SL , Stittelaar KJ , Gast C , Weldon WC , Konopka-Anstadt JL , Oberste MS , Van Damme P , De Coster I , Rüttimann R , Bandyopadhyay A , Konz J . NPJ Vaccines 2021 6 (1) 94
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials. Sáez-Llorens X , Bandyopadhyay AS , Gast C , Leon T , DeAntonio R , Jimeno J , Caballero MI , Aguirre G , Oberste MS , Weldon WC , Konopka-Anstadt JL , Modlin J , Bachtiar NS , Fix A , Konz J , Clemens R , Costa Clemens SA , Rüttimann R . Lancet 2020 397 (10268) 27-38
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials. De Coster I , Leroux-Roels I , Bandyopadhyay AS , Gast C , Withanage K , Steenackers K , De Smedt P , Aerssens A , Leroux-Roels G , Oberste MS , Konopka-Anstadt JL , Weldon WC , Fix A , Konz J , Wahid R , Modlin J , Clemens R , Costa Clemens SA , Bachtiar NS , Van Damme P . Lancet 2020 397 (10268) 39-50
Updated Characterization of Outbreak Response Strategies for 2019-2029: Impacts of Using a Novel Type 2 Oral Poliovirus Vaccine Strain. Kalkowska DA , Pallansch MA , Wilkinson A , Bandyopadhyay AS , Konopka-Anstadt JL , Burns CC , Oberste MS , Wassilak SGF , Badizadegan K , Thompson KM . Risk Anal 2020 41 (2) 329-348
Development of a new oral poliovirus vaccine for the eradication end game using codon deoptimization. Konopka-Anstadt JL , Campagnoli R , Vincent A , Shaw J , Wei L , Wynn NT , Smithee SE , Bujaki E , Te Yeh M , Laassri M , Zagorodnyaya T , Weiner AJ , Chumakov K , Andino R , Macadam A , Kew O , Burns CC . NPJ Vaccines 2020 5 (1) 26
Pan-viral serology implicates enteroviruses in acute flaccid myelitis. Schubert RD , Hawes IA , Ramachandran PS , Ramesh A , Crawford ED , Pak JE , Wu W , Cheung CK , O'Donovan BD , Tato CM , Lyden A , Tan M , Sit R , Sowa GA , Sample HA , Zorn KC , Banerji D , Khan LM , Bove R , Hauser SL , Gelfand AA , Johnson-Kerner BL , Nash K , Krishnamoorthy KS , Chitnis T , Ding JZ , McMillan HJ , Chiu CY , Briggs B , Glaser CA , Yen C , Chu V , Wadford DA , Dominguez SR , Ng TFF , Marine RL , Lopez AS , Nix WA , Soldatos A , Gorman MP , Benson L , Messacar K , Konopka-Anstadt JL , Oberste MS , DeRisi JL , Wilson MR . Nat Med 2019 25 (11) 1748-1752
Antibodies to Enteroviruses in Cerebrospinal Fluid of Patients with Acute Flaccid Myelitis. Mishra N , Ng TFF , Marine RL , Jain K , Ng J , Thakkar R , Caciula A , Price A , Garcia JA , Burns JC , Thakur KT , Hetzler KL , Routh JA , Konopka-Anstadt JL , Nix WA , Tokarz R , Briese T , Oberste MS , Lipkin WI . mBio 2019 10 (4)